Welcome!

News Feed Item

Easton Pharmaceuticals Announces 2 Medical Marijuana Investment Proposals Which Include the Launch of Medical Marijuana Dispensary(s) in the State of Michigan and an Investment Into Medical Marijuana Technologies to Assist Growers With Harvests

TORONTO, ON -- (Marketwired) -- 06/06/14 -- Easton Pharmaceuticals Inc. -- (OTC: EAPH) -- announces it has received and is in late stage discussions with two investment proposals in the medical marijuana industry.

Easton Pharmaceuticals will be decided upon within the next week to 10 days which involves two proposals and investment opportunities in the medical marijuana industry. The first proposal stems from a signed LOI and discussions initiated with UMED Health and Wellness Centers located in the State of Michigan, current owners of an operating medical marijuana dispensary since January of this year. The discussions with UMED involve terms based around Easton Pharmaceuticals opening one or possibly more medical marijuana dispensary(s) in the State of Michigan with UMED being the manager of the operating business and facility. A counter proposal has been submitted to UMED where both companies would form a 50/50 joint partnership for new dispensaries with Easton paying the fees and expenses required to open the facilities and UMED finding the locations, design, launch the facilities, locate the product and patients for the dispensary. Discussions have also involved a direct investment into UMED for expansion of their existing business which after 6 months of operations with their own dispensary, revenues according to UMED are projected to conservatively reach $1 Million at the current pace with cumulative increases projected over the next few years. The new dispensaries in Michigan is thought of as an attractive opportunity to generate quick low overhead revenues for Easton due to costs that are deemed to be greatly reduced compared to the current costs required for its federal medical marijuana growers business in Canada as previously announced with MDRM Canada Group Inc. currently in its final inspection phase prior to receiving a Federal growers license for the entire country of Canada. The launch of dispensaries(s) in the state of Michigan does not presently require elaborate vaults or other expensive security systems as is required as per federal guidelines in Canada although dispensary's in Michigan are not legally allowed to grow their own product, but to only distribute medical marijuana to patients. Through consultations with advisors and other experts in the industry, with the ever improving sentiment to medical marijuana and to recreational use marijuana as is the case in the precedent setting, State of Colorado, eventually cross border or cross state importing and exporting of various strains of marijuana is believed to be approved. Easton Pharmaceuticals believes now would be the opportune time to get involved in the State of Michigan for Medical Marijuana before new rules are expected to come into effect resulting in more strict licensing requirements, security and other facets which would greatly increase the costs which as of the moment are a fraction compared to Canada's highly regulated, but extremely profitable industry or of that in other states such as Colorado and others.

In addition to the Michigan medical marijuana initiative, Easton has been presented with an opportunity to invest in a private company, soon to go public, to help fund a leading technology designed to ensure that cultivation, bottling, edible, extract manufacturers and dispensaries all maintain the highest food quality safety standards for antimicrobial and bacteria free facilities. In the wake of Colorado recently sending health inspectors to numerous facilities where large harvests were ordered destroyed and or recalled which was the same for large growers in Canada, this technology could save industry companies hundreds of thousands of dollars in lost revenue and brand damage. Colorado has announced new health standards and bacteria testing procedures will be coming into place by October. Other states will soon follow which is why an opportunity does exist and where Easton may conclude a deal next week.

A decision on both of the proposals and opportunities are expected to be made in the next week to 10 days and neither requires a large investment by Easton which would not impede or limit the closing of its recently announced MDRM Canada Group agreement where Easton has an exclusive option to purchase up to 49% in a private medical marijuana company who are in receipt of a letter to build from health Canada and are in the final build out stage of its facilities prior to a final inspection and before a national MMPR growers license is granted.

In other news, Easton Pharmaceuticals is placing serious consideration to moving forward with filing a form 10 or an S1 with the Securities and Exchange Commission to become a reporting issuer and to graduate up to the OTCBB or the OTCQB exchange. The difference with being an SEC reporting company is that its financial statements would be audited by a US GAAP auditor and filed on the SEC's Edgar system. Currently, its financial statements are validated by an attorney and filed on the OTC Markets exchange (OTC: EAPH) which is considered close to the same level of transparency with financial statements filed with the SEC, being a reporting SEC filer would require 8K's and other filings to be submitted on a more timely basis for material transactions.

About Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors including medical marijuana, that owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues related towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company's gel formulation is thought to be an innovative and unique transdermal delivery system. Easton Pharmaceuticals' product "VIORRA" is an over-the-counter, topical daily use product and aid for the treatment to restore and improve vaginal moisture and elasticity which is believed to have a positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder); the world market for these female conditions and the medical marijuana industry is conservatively estimated to be in the billions.

For More Information Visit:
http://www.eastonpharmaceuticalsinc.com

Safe Harbor

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. There are no guarantees or assurances that any proposals, initiatives or negotiations will result in what the company had originally intended. Any investment made into Easton Pharmaceuticals would be classified as speculative and risky. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.

Contact:

Carla Pepe
Easton Pharmaceuticals Inc.
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email:
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
"Digital transformation - what we knew about it in the past has been redefined. Automation is going to play such a huge role in that because the culture, the technology, and the business operations are being shifted now," stated Brian Boeggeman, VP of Alliances & Partnerships at Ayehu, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
"WineSOFT is a software company making proxy server software, which is widely used in the telecommunication industry or the content delivery networks or e-commerce," explained Jonathan Ahn, COO of WineSOFT, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
There is a huge demand for responsive, real-time mobile and web experiences, but current architectural patterns do not easily accommodate applications that respond to events in real time. Common solutions using message queues or HTTP long-polling quickly lead to resiliency, scalability and development velocity challenges. In his session at 21st Cloud Expo, Ryland Degnan, a Senior Software Engineer on the Netflix Edge Platform team, will discuss how by leveraging a reactive stream-based protocol,...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
Sanjeev Sharma Joins June 5-7, 2018 @DevOpsSummit at @Cloud Expo New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...